|
|
 |
|
Viewing report
|
|
|
|
Interstitial Cystitis - Few Treatments, Poor Outcome
Datamonitor, April 2006, Pages: 50
Interstitial cystitis (IC) is considered a rare disorder and poor understanding of the underlying causes of the disorder have made diagnosis and management difficult. Moreover, this has impacted on the development of effective drugs for this disorderthere are few available treatments for IC and as a result, significant unmet needs exist.
Scope of this title:
- Quantitative treatment data from 190 physicians based in US, Japan, France, Germany, Italy, Spain and UK; supported by key opinion leader comments
- Analysis of epidemiology, presentation and referral patterns, diagnostic assessment, and first- to second-line treatments for IC
- Influences on treatment choice and perception of current drug therapies including pentosan polysulfate sodium and the antimuscarinics
- Influences on treatment choice and perception of current drug therapies, unmet needs and future outlook including the R&D drug pipeline
Highlights of this title:
Presentation rates for IC are higher than in other OAB disorders due to the patient experience of pain. However, discord in the terminology and diagnostic criteria for IC confound diagnosis; and as result, the diagnosis of IC tends to be one of exclusion, and as such can take many years to be reached, bringing unnecessary suffering to the patient.
IC symptoms have a similar terminology to those of Overactive Bladder, but are fundamentally different. Poor understanding of the disorder and limited treatment options means that many physicians have resorted to using antimuscarinics despite their limited proven efficacy in treating the pain.
Further research into the etiology of IC is the key to finding a truly effective treatment for IC that works. In the meantime, companies wishing to target the IC market should aim to demonstrate the ability of their drug to treat pain in addition to urgency and frequency.
Reasons to order your copy:
- Forecast product sales by understanding key aspects of IC epidemiology, diagnosis and treatment
- Gain a better understanding of the challenges facing current and future players in the IC market
- Identify physicians’ key concerns in IC including unmet needs and the attributes that physicians believe are desirable for future treatments
Customers who bought this item also bought
Neuropathic Pain: Treatments and Prescribing Practices - A Global Survey 2009
Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need?
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment
Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice
Treatment Algorithms: Cancer Pain - Physician Awareness and Novel Drug Delivery Will Drive Market Opportunities
Back Pain Report 2008
Cardiac Care � Trends in Diagnosis and Treatment
Special Report: Understanding Treatment Dynamics and Needs in Juvenile Idiopathic Arthritis
Management of Urinary Incontinence and Overactive Bladder - A Global Overview
US Cancer Pain Report
Pain Therapeutics - Drugs, Markets and Companies
Systemic Lupus Erythematosus Imprecise Segmentation Complicates Treatment Algorithms
|
|
|
|
